Coya Therapeutics Hosts Webinar on Head Trauma, Inflammation, and Neurodegenerative Disease
Event summary
- Coya Therapeutics will host a live webinar on June 24, 2026, at 4 p.m. ET / 1 p.m. PT.
- The webinar will explore the relationship between repetitive head trauma, chronic inflammation, and neurodegenerative diseases like CTE and ALS.
- Participants include NFL broadcaster Solomon Wilcots, neurology professor Stanley H. Appel, M.D., Coya's President and Chief Medical Officer Fred Grossman D.O., and sports agent Leigh Steinberg.
- Pre-registration is open, and a recording will be posted to Coya's website post-event.
The big picture
Coya Therapeutics' webinar underscores the growing recognition of the link between repetitive head trauma and neurodegenerative diseases, positioning the company at the forefront of research into Treg-based therapies. The event highlights the intersection of sports advocacy, clinical neurology, and therapeutic innovation, reflecting broader industry trends toward targeted immune modulation in neurodegenerative conditions.
What we're watching
- Clinical Development
- How insights from the webinar may influence Coya's pipeline strategies for neurodegenerative diseases.
- Market Positioning
- Whether the event enhances Coya's visibility among investors and potential partners in the neuroinflammation space.
- Regulatory Landscape
- The pace at which regulatory pathways for Treg-based therapies may evolve following broader industry discussions.
Related topics